7Baggers
 published on: 2025-09-28 23:20:32  newser.com Mon, 29 Sep 2025 04:20:32 GMT
 published on: 2025-09-22 00:55:26  newser.com Mon, 22 Sep 2025 05:55:26 GMT
 published on: 2025-09-21 07:32:21  خودرو بانک Sun, 21 Sep 2025 04:05:29 GMT
 published on: 2025-09-04 06:04:18  Newser Thu, 04 Sep 2025 11:04:18 GMT
 published on: 2025-09-03 02:00:30  Newser Wed, 03 Sep 2025 07:00:30 GMT
 TransCode Therapeutics shareholders approve all proposals at annual meeting  Investing.com India Wed, 03 Sep 2025 07:00:00 GMT
 transcode therapeutics passes key proposals at annual meeting  TipRanks Tue, 02 Sep 2025 07:00:00 GMT
 published on: 2025-08-30 21:57:22  Newser Sun, 31 Aug 2025 02:57:22 GMT
 published on: 2025-08-30 14:49:28  Newser Sat, 30 Aug 2025 19:49:28 GMT
 published on: 2025-08-27 05:00:21  Newser Wed, 27 Aug 2025 10:00:21 GMT

TransCode Therapeutics Inc
(NASDAQ:RNAZ) 

RNAZ stock logo

TransCode Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing drugs for treating metastatic disease. The Company's development pipeline includes TTX-MC138, TTX-siPD-L1 and TTX-RIGA, TTX-siLIN28B, and TCD-miR10b.

Founded: 2016
CEO / Co-Founder: Michael Dudley 
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology

Share this website to your friends